Literature DB >> 15877762

Annotation: velo-cardio-facial syndrome.

K C Murphy1.   

Abstract

BACKGROUND: Velo-cardio-facial syndrome (VCFS), the most frequent known interstitial deletion identified in man, is associated with chromosomal microdeletions in the q11 band of chromosome 22. Individuals with VCFS are reported to have a characteristic behavioural phenotype with high rates of behavioural, psychiatric, neuropsychological and linguistic disorders.
METHODS: A selective literature review was undertaken.
RESULTS: Children and adults with VCFS have high rates of behavioural, psychiatric and communication disorders. While VCFS children have high rates of ADHD, anxiety and affective disorders, adults have high rates of psychotic disorders, particularly schizophrenia. In addition, the presence of a chromosome 22q11 deletion is associated with specific neuropsychological and neuroanatomical abnormalities.
CONCLUSIONS: People with VCFS have a characteristic behavioural phenotype with high rates of behavioural, psychiatric, neuropsychological and communication disorders. Early diagnosis and treatment within a multidisciplinary framework is of paramount importance for VCFS individuals as this will have a major effect in determining the long-term outcome in affected individuals. Longitudinal studies of VCFS children are currently under way to identify precursor symptoms and areas of dysfunction which precede the later development of major psychiatric disorder. Identification of such prodromal features in VCFS may have enormous implications for the clinical management of major psychiatric disorder in VCFS and in the wider population.

Entities:  

Mesh:

Year:  2005        PMID: 15877762     DOI: 10.1111/j.1469-7610.2005.00408.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  12 in total

1.  Response to clozapine in psychosis associated with velo-cardio-facial syndrome.

Authors:  Adeeb Yacoub; Maria Aybar
Journal:  Psychiatry (Edgmont)       Date:  2007-05

Review 2.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

3.  Treatment resistant psychosis in an adolescent with scoliosis and a history of early feeding difficulties.

Authors:  Hilary Le Page
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2006-11

4.  Facial emotion perception by intensity in children and adolescents with 22q11.2 deletion syndrome.

Authors:  Arnaud Leleu; Guillaume Saucourt; Caroline Rigard; Gabrielle Chesnoy; Jean-Yves Baudouin; Massimiliano Rossi; Patrick Edery; Nicolas Franck; Caroline Demily
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-07-07       Impact factor: 4.785

5.  Delineation of behavioral phenotypes in genetic syndromes: characteristics of autism spectrum disorder, affect and hyperactivity.

Authors:  Chris Oliver; Katy Berg; Jo Moss; Kate Arron; Cheryl Burbidge
Journal:  J Autism Dev Disord       Date:  2011-08

6.  Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS).

Authors:  Alice Fabbro; Eleonora Rizzi; Maude Schneider; Martin Debbane; Stephan Eliez
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-04-19       Impact factor: 4.785

7.  Collection of developmental history in the evaluation of schizophrenia spectrum disorders.

Authors:  Angela M Reiersen
Journal:  Scand J Child Adolesc Psychiatr Psychol       Date:  2016

8.  Analysis of TBX1 variation in patients with psychotic and affective disorders.

Authors:  Birgit H Funke; Todd Lencz; Christine T Finn; Pamela DeRosse; G David Poznik; Alex M Plocik; John Kane; John Rogus; Anil K Malhotra; Raju Kucherlapati
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

9.  Is theory of mind related to social dysfunction and emotional problems in 22q11.2 deletion syndrome (velo-cardio-facial syndrome)?

Authors:  Linda E Campbell; Angela F Stevens; Kathryn McCabe; Lynne Cruickshank; Robin G Morris; Declan G M Murphy; Kieran C Murphy
Journal:  J Neurodev Disord       Date:  2011-05-05       Impact factor: 4.025

10.  Evidence for involvement of GNB1L in autism.

Authors:  Ying-Zhang Chen; Mark Matsushita; Santhosh Girirajan; Mark Lisowski; Elizabeth Sun; Youngmee Sul; Raphael Bernier; Annette Estes; Geraldine Dawson; Nancy Minshew; Gerard D Shellenberg; Evan E Eichler; Mark J Rieder; Deborah A Nickerson; Debby W Tsuang; Ming T Tsuang; Ellen M Wijsman; Wendy H Raskind; Zoran Brkanac
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-11-16       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.